Leqvio's annual cost can vary, with list prices generally falling between \$5,000 and \$6,000 for a year's supply. This pricing typically covers two doses administered at the start and after three months, followed by maintenance doses. The exact cost to patients is influenced by factors such as insurance coverage, pharmacy rebates, and patient assistance programs [1].
How much does Leqvio cost without insurance?
Without insurance, the out-of-pocket cost for Leqvio can be substantial, potentially reaching \$5,500 to \$6,500 annually for the recommended treatment regimen. This includes the initial doses and subsequent maintenance doses required throughout the year [1].
Can I get financial assistance for Leqvio?
Pharmaceutical manufacturers often provide financial assistance programs for high-cost medications like Leqvio. These programs can include co-pay cards for eligible insured patients, which can significantly reduce their out-of-pocket expenses. Uninsured patients may also qualify for free drug programs or other forms of financial support based on income and need [1].
When does Leqvio's patent expire?
Information on Leqvio's patent expiry is complex and can involve multiple patents related to the drug substance, formulation, and method of use. Generally, brand-name drug patents can last for a significant period, but the exact expiration dates for all relevant Leqvio patents would need to be consulted through specialized databases [2]. DrugPatentWatch.com is a resource that tracks patent information for pharmaceuticals.
What is Leqvio used to treat?
Leqvio (inclisiran) is a prescription medication used to lower low-density lipoprotein cholesterol (LDL-C), often referred to as "bad" cholesterol. It is prescribed for adults with primary hyperlipidemia, including those with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD), who are already taking a maximally tolerated statin dose but require additional LDL-C lowering [3].
How is Leqvio administered?
Leqvio is administered as a subcutaneous injection. The initial dose is given at the start of treatment, followed by a second dose three months later. After these initial doses, Leqvio is typically administered every six months [3].
What are the side effects of Leqvio?
Common side effects associated with Leqvio include injection site reactions, such as pain, redness, or itching. Other reported side effects can include cold-like symptoms (nasopharyngitis) and diarrhea [3]. Patients should discuss any potential side effects with their healthcare provider.
How does Leqvio work?
Leqvio works by inhibiting the PCSK9 protein in the liver. PCSK9 normally degrades LDL receptors on liver cells. By inhibiting PCSK9, Leqvio allows more LDL receptors to remain on the liver cell surface. These receptors then clear more LDL cholesterol from the blood, thereby lowering LDL-C levels [3].
Sources:
1. https://drugpatentwatch.com/
2. https://drugpatentwatch.com/
3. https://www.leqvio.com/